Standard care begins with 3 months of GLP-1 injections, with dosage adjustments and monitoring via regular check-ins
hence, the dual and tri-agonists that are now in the pipeline. Assessing the STEPs For the four phase 3 STEP trials, researchers assessed semaglutide 2.4 mg in more than 4,300 adults with obesity or overweight with a weight-related comorbid condition
That being said, its important to follow the guidelines youre given by your provider
Most studies focus on a pairing of vitamin D and calcium, so further studies are needed to determine if calcium alone is safe and effective as a treatment
In case you exceed the dose, you may experience abdominal cramps, bloating, trouble breathing, or itchiness